|
humans |
22 |
|
male |
17 |
|
cell line, tumor |
16 |
|
apoptosis |
15 |
|
metastasis |
15 |
|
nasopharyngeal carcinoma |
14 |
|
female |
13 |
|
immortalization |
13 |
|
esophageal squamous cell carcinoma |
12 |
|
tumor cells, cultured |
12 |
|
esophageal cancer |
11 |
|
medical sciences |
11 |
|
nf-κb |
11 |
|
telomerase |
11 |
|
chemoresistance |
10 |
|
dna methylation |
10 |
|
epstein-barr virus |
10 |
|
escc |
10 |
|
esophageal |
10 |
|
animals |
9 |
|
chromosome aberrations |
9 |
|
dose-response relationship, drug |
9 |
|
lmp1 |
9 |
|
neoplasm invasiveness |
9 |
|
oncology |
9 |
|
p21 |
9 |
|
pi3k/akt |
9 |
|
aged |
8 |
|
cell cycle proteins - genetics - metabolism |
8 |
|
cell survival - physiology |
8 |
|
e-cadherin |
8 |
|
egfr |
8 |
|
etv4 |
8 |
|
immunohistochemistry |
8 |
|
nrp2 |
8 |
|
rna, messenger - genetics - metabolism |
8 |
|
rna‐seq |
8 |
|
antineoplastic agents - pharmacology |
7 |
|
apoptosis - drug effects |
7 |
|
berberine |
7 |
|
berberine - administration & dosage - pharmacology |
7 |
|
cell migration |
7 |
|
cell movement - drug effects |
7 |
|
cell proliferation - drug effects |
7 |
|
cell transformation, neoplastic |
7 |
|
centromere |
7 |
|
centromere - drug effects - metabolism |
7 |
|
chfr |
7 |
|
chromosomal instability |
7 |
|
chromosomal instability - genetics |
7 |
|
circulating mirna |
7 |
|
cpg islands - genetics |
7 |
|
cyclin b1 - genetics - metabolism |
7 |
|
cyclin d1 - genetics - metabolism |
7 |
|
defect |
7 |
|
diagnosis and prognosis |
7 |
|
epigenesis, genetic - genetics |
7 |
|
episome |
7 |
|
epstein-barr virus infections - complications - genetics - metabolism - virology |
7 |
|
esophageal neoplasms - genetics - metabolism - pathology |
7 |
|
g 2 checkpoint |
7 |
|
g2 arrest |
7 |
|
g2 phase - drug effects |
7 |
|
g2 phase - genetics |
7 |
|
gene expression regulation, neoplastic - genetics |
7 |
|
gene silencing |
7 |
|
herpesvirus 4, human - genetics - pathogenicity |
7 |
|
id‐1 |
7 |
|
instability |
7 |
|
microrna therapy |
7 |
|
middle aged |
7 |
|
mir‐338‐5p |
7 |
|
mitosis |
7 |
|
nasopharyngeal neoplasms |
7 |
|
nasopharyngeal neoplasms - genetics - pathology |
7 |
|
nasopharynx - metabolism - pathology - virology |
7 |
|
neoplasm metastasis |
7 |
|
neoplasm proteins - genetics - metabolism |
7 |
|
p38 signaling |
7 |
|
plant extracts - pharmacology |
7 |
|
promoter hypermethylation |
7 |
|
promoter regions, genetic - genetics |
7 |
|
rho gtp-binding proteins - antagonists & inhibitors - metabolism |
7 |
|
rho gtpases |
7 |
|
stat5a |
7 |
|
viral persistence |
7 |
|
ampk |
6 |
|
blotting, western |
6 |
|
cancer progression |
6 |
|
cell line |
6 |
|
cell movement |
6 |
|
cpg islands |
6 |
|
down-regulation |
6 |
|
erk1/2 |
6 |
|
fluorescent antibody technique |
6 |
|
gene expression regulation, neoplastic |
6 |
|
genomic instability |
6 |
|
in situ hybridization, fluorescence |
6 |
|
inhibitor of differentiation protein 1 - metabolism |
6 |
|
mtor |
6 |
|
p53 |
6 |
|
prostate cancer |
6 |
|
silibinin |
6 |
|
spectral karyotyping |
6 |
|
targeted therapy |
6 |
|
adult |
5 |
|
alk |
5 |
|
beta catenin |
5 |
|
biomarker |
5 |
|
bmi-1 |
5 |
|
cadherins - biosynthesis |
5 |
|
cadherins - genetics - metabolism |
5 |
|
cancer |
5 |
|
cell cycle - physiology |
5 |
|
cell line, transformed |
5 |
|
cell transformation, neoplastic - genetics - metabolism - pathology |
5 |
|
cervical epithelial cells |
5 |
|
cyclin e |
5 |
|
cytoskeletal proteins - biosynthesis |
5 |
|
dna damage |
5 |
|
down-regulation - genetics |
5 |
|
enzyme inhibitors - pharmacology |
5 |
|
epithelial cells - cytology |
5 |
|
epithelial cells - metabolism - pathology |
5 |
|
esophagus - metabolism - pathology - physiology |
5 |
|
esptein-barr virus |
5 |
|
gene expression |
5 |
|
hpv-negative |
5 |
|
id-1 |
5 |
|
immunoenzyme techniques |
5 |
|
karyotype |
5 |
|
kras |
5 |
|
lung adenocarcinomas |
5 |
|
methylation |
5 |
|
microtubules |
5 |
|
microtubules - metabolism - pathology |
5 |
|
midkine |
5 |
|
nasopharyngeal epithelial carcinoma |
5 |
|
nasopharyngeal epithelial cells |
5 |
|
nasopharyngeal neoplasms - metabolism |
5 |
|
nasopharynx - cytology |
5 |
|
neoplasms, squamous cell - genetics - metabolism - pathology |
5 |
|
oncogenic mutations |
5 |
|
p16 ink4a |
5 |
|
p16ink4a |
5 |
|
premalignant nasopharyngeal epithelium |
5 |
|
rassf1a |
5 |
|
rats |
5 |
|
replicative stress |
5 |
|
reverse transcriptase polymerase chain reaction - methods |
5 |
|
rna, messenger - metabolism |
5 |
|
rna, neoplasm - metabolism |
5 |
|
serglycin |
5 |
|
squamous cell carcinoma |
5 |
|
telomerase - biosynthesis |
5 |
|
telomerase - biosynthesis - genetics |
5 |
|
transfection |
5 |
|
tumor suppressor proteins - antagonists and inhibitors - biosynthesis - genetics |
5 |
|
tumorigenesis |
5 |
|
viral matrix proteins - biosynthesis |
5 |
|
β-catenin |
5 |
|
aberrations |
4 |
|
aged, 80 and over |
4 |
|
alpha-tocopherol - analysis |
4 |
|
antibody therapy |
4 |
|
asia, southeastern - epidemiology |
4 |
|
azacitidine - analogs & derivatives - pharmacology |
4 |
|
bcl-2 |
4 |
|
bone marrow-derived cells |
4 |
|
breast cancer |
4 |
|
cadherins - biosynthesis - genetics |
4 |
|
calcium-binding proteins - biosynthesis |
4 |
|
calcium-binding proteins - biosynthesis - genetics |
4 |
|
carcinogenesis |
4 |
|
carcinoma - genetics - metabolism |
4 |
|
carcinoma, non-small-cell lung - enzymology - genetics - pathology |
4 |
|
carcinoma, squamous cell - genetics - metabolism - pathology |
4 |
|
carcinoma, squamous cell - metabolism - pathology |
4 |
|
caveolin 1 - metabolism |
4 |
|
cell cycle arrest |
4 |
|
cell cycle proteins |
4 |
|
cell cycle proteins - biosynthesis |
4 |
|
cell proliferation |
4 |
|
cell transformation, viral - genetics |
4 |
|
cells, cultured |
4 |
|
centrosome |
4 |
|
centrosome - metabolism - pathology |
4 |
|
checkpoint kinase 1 |
4 |
|
chromatid aberration |
4 |
|
chromones - pharmacology |
4 |
|
chromosome fragility - genetics |
4 |
|
chromosome painting - methods - statistics & numerical data |
4 |
|
chromosome segregation |
4 |
|
chromosomes, human - genetics |
4 |
|
chromosomes, human - genetics - physiology |
4 |
|
chromosomes, human, pair 12 - genetics |
4 |
|
chromosomes, human, pair 3 - genetics |
4 |
|
cisplatin |
4 |
|
cisplatin - pharmacology |
4 |
|
comparative genomic hybridization |
4 |
|
cpg island methylation |
4 |
|
cricetinae |
4 |
|
culture media - pharmacology |
4 |
|
culture media, serum-free - pharmacology |
4 |
|
cyclin-dependent kinase inhibitor p16 - metabolism |
4 |
|
cyclin-dependent kinase inhibitor p21 - metabolism |
4 |
|
dietary fat |
4 |
|
dietary fats - administration & dosage |
4 |
|
dna modification methylases - antagonists & inhibitors |
4 |
|
dna probes |
4 |
|
dna, antisense - genetics |
4 |
|
dna, neoplasm - analysis |
4 |
|
dna-binding proteins - analysis - genetics |
4 |
|
drug resistance, neoplasm |
4 |
|
enzyme activation |
4 |
|
epithelial cells - chemistry - metabolism - pathology |
4 |
|
epithelium - metabolism |
4 |
|
esophageal carcinoma |
4 |
|
esophageal neoplasms - enzymology - metabolism - pathology |
4 |
|
esophageal neoplasms - genetics - metabolism |
4 |
|
esophageal neoplasms - metabolism - pathology |
4 |
|
fbxo31 |
4 |
|
flow cytometry |
4 |
|
g2 phase |
4 |
|
g2/m cell cycle |
4 |
|
gene expression - drug effects |
4 |
|
genome |
4 |
|
genome, human |
4 |
|
hela cells |
4 |
|
human |
4 |
|
in situ hybridization, fluorescence - methods - statistics & numerical data |
4 |
|
incidence |
4 |
|
inhibitor of differentiation protein 1 - genetics - metabolism - physiology |
4 |
|
inhibitor of differentiation protein 1 - genetics - physiology |
4 |
|
inhibitor of differentiation protein 1 - physiology |
4 |
|
jnk |
4 |
|
karyotyping |
4 |
|
latent membrane protein 1 |
4 |
|
lung neoplasms - enzymology - genetics - pathology |
4 |
|
mad2 |
4 |
|
mammary neoplasms, experimental - blood - etiology - pathology |
4 |
|
mdm2 |
4 |
|
mesocricetus |
4 |
|
mesoderm - metabolism |
4 |
|
mice |
4 |
|
mice, inbred balb c |
4 |
|
mice, nude |
4 |
|
microtubules - genetics - pathology |
4 |
|
mitosis - drug effects |
4 |
|
mitosis - physiology |
4 |
|
mitotic checkpoint |
4 |
|
mitotic index |
4 |
|
models, genetic |
4 |
|
molecular sequence data |
4 |
|
morpholines - pharmacology |
4 |
|
nasopharyngeal neoplasms - epidemiology - genetics - pathology |
4 |
|
nerve tissue proteins - biosynthesis |
4 |
|
nf-kappa b - metabolism |
4 |
|
noble rats |
4 |
|
nocodazole - pharmacology |
4 |
|
non-small cell lung cancer |
4 |
|
normal and pathological pregnancies |
4 |
|
nucleic acid hybridization |
4 |
|
ovarian neoplasms - genetics - metabolism - pathology |
4 |
|
ovary - pathology |
4 |
|
p38α mapk |
4 |
|
paclitaxel - pharmacology |
4 |
|
phosphatidylinositol 3-kinases - antagonists & inhibitors - metabolism |
4 |
|
phosphatidylinositol 3-kinases - metabolism |
4 |
|
phosphorylation |
4 |
|
placenta accreta - metabolism - pathology |
4 |
|
plasmids - genetics |
4 |
|
polymerase chain reaction |
4 |
|
pre-eclampsia - metabolism - pathology |
4 |
|
pregnancy |
4 |
|
proliferation |
4 |
|
promoter regions, genetic |
4 |
|
prostatic neoplasms |
4 |
|
prostatic neoplasms - blood - etiology - pathology |
4 |
|
prostatic neoplasms - metabolism - pathology |
4 |
|
protein binding |
4 |
|
proto-oncogene proteins c-akt - metabolism |
4 |
|
proto-oncogene proteins c-mdm2 - metabolism |
4 |
|
repressor proteins |
4 |
|
repressor proteins - biosynthesis |
4 |
|
retinoblastoma protein - metabolism |
4 |
|
reverse transcriptase polymerase chain reaction |
4 |
|
rna, neoplasm - biosynthesis |
4 |
|
rna, small interfering - genetics |
4 |
|
seminoma - metabolism - pathology |
4 |
|
signal transduction |
4 |
|
signal transduction - physiology |
4 |
|
smad2 protein |
4 |
|
staining and labeling |
4 |
|
survival |
4 |
|
telomerase - metabolism |
4 |
|
telomerase activity |
4 |
|
telomere |
4 |
|
telomere - genetics - metabolism - physiology |
4 |
|
telomere - genetics - pathology |
4 |
|
telomeres |
4 |
|
testicular germ cell tumour |
4 |
|
testicular neoplasms - metabolism - pathology |
4 |
|
testis - metabolism - pathology |
4 |
|
testosterone - blood - pharmacology |
4 |
|
time factors |
4 |
|
trans-activators - analysis - genetics |
4 |
|
trans-activators - biosynthesis |
4 |
|
transcription, genetic |
4 |
|
trophoblastic neoplasms - metabolism - pathology |
4 |
|
trophoblastic tissue |
4 |
|
trophoblasts - metabolism - pathology |
4 |
|
tumor angiogenesis |
4 |
|
tumor growth |
4 |
|
tumor microenvironment |
4 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
4 |
|
tumor suppressor protein p53 - deficiency - metabolism |
4 |
|
tumorigenicity |
4 |
|
two-hybrid system techniques |
4 |
|
uterine neoplasms - metabolism - pathology |
4 |
|
vegf receptors |
4 |
|
vitamin e |
4 |
|
wound healing |
4 |
|
xenograft model antitumor assays |
4 |
|
20q amplification |
3 |
|
alkalies |
3 |
|
amino acid motifs |
3 |
|
angiogenesis - cancer |
3 |
|
animals, newborn |
3 |
|
antigens, cd - genetics - metabolism |
3 |
|
antigens, cd95 - metabolism |
3 |
|
antioxidants - metabolism |
3 |
|
apoptosis - physiology |
3 |
|
aurora kinase a |
3 |
|
autoantigens - genetics - metabolism |
3 |
|
avulsion |
3 |
|
axons - physiology |
3 |
|
axotomy |
3 |
|
base sequence |
3 |
|
bax |
3 |
|
bcl-2-associated x protein |
3 |
|
bullous pemphigoid antigen |
3 |
|
butadienes - pharmacology |
3 |
|
cadherins - metabolism |
3 |
|
calcium-binding proteins - genetics - metabolism |
3 |
|
calcium-binding proteins - pharmacology |
3 |
|
carcinoma |
3 |
|
carcinoma - metabolism - mortality - pathology |
3 |
|
carcinoma, non-small-cell lung - genetics - metabolism |
3 |
|
carcinoma, squamous cell - genetics - metabolism |
3 |
|
carcinoma, squamous cell - genetics - pathology - virology |
3 |
|
carcinoma, squamous cell - virology |
3 |
|
carrier proteins |
3 |
|
catalase |
3 |
|
catalase - metabolism |
3 |
|
cell aging - drug effects - physiology |
3 |
|
cell cycle proteins - genetics |
3 |
|
cell cycle proteins - pharmacology |
3 |
|
cell death |
3 |
|
cell division |
3 |
|
cell division - drug effects |
3 |
|
china |
3 |
|
chorionic gonadotropin - pharmacology |
3 |
|
chromosome mapping |
3 |
|
chromosome spreading |
3 |
|
chromosomes - genetics - ultrastructure |
3 |
|
chromosomes, human, pair 11 - genetics |
3 |
|
chromosomes, human, pair 20 - genetics |
3 |
|
chromosomes, human, pair 7 - genetics |
3 |
|
cisplatin - therapeutic use |
3 |
|
collagen - genetics - metabolism |
3 |
|
copulation |
3 |
|
cytogenetic analysis - instrumentation - methods |
3 |
|
cytoskeletal proteins |
3 |
|
disease models, animal |
3 |
|
dna - genetics - metabolism |
3 |
|
dna - metabolism |
3 |
|
dna damage - genetics |
3 |
|
dna damage - physiology |
3 |
|
dna primers |
3 |
|
dna repair |
3 |
|
dna repair - genetics |
3 |
|
dna, single-stranded - metabolism |
3 |
|
dna-binding proteins - genetics |
3 |
|
dna-binding proteins - metabolism |
3 |
|
dynamics |
3 |
|
emt |
3 |
|
epidermal growth factor receptor |
3 |
|
epithelial cells - enzymology |
3 |
|
epithelial-mesenchymal transition |
3 |
|
esophageal neoplasms - genetics - pathology - virology |
3 |
|
esophageal neoplasms - virology |
3 |
|
f-box protein |
3 |
|
fas ligand protein |
3 |
|
fibroblast growth factor 3 |
3 |
|
fibroblast growth factor 3 - genetics - metabolism |
3 |
|
fibroblasts |
3 |
|
fixatives - pharmacology |
3 |
|
food, formulated - adverse effects |
3 |
|
formaldehyde - pharmacology |
3 |
|
galactose - adverse effects - metabolism |
3 |
|
galactosemia |
3 |
|
galactosemias - complications - metabolism - pathology |
3 |
|
gene amplification |
3 |
|
gene expression regulation - drug effects |
3 |
|
gene expression regulation, enzymologic |
3 |
|
genitalia, male - enzymology |
3 |
|
glutathione peroxidase |
3 |
|
glutathione peroxidase - metabolism |
3 |
|
gonadotropins, equine - pharmacology |
3 |
|
granulosa cells |
3 |
|
granulosa cells - metabolism - pathology |
3 |
|
hemidesmosome |
3 |
|
hemidesmosomes - genetics - metabolism |
3 |
|
herpesvirus 4, human - metabolism |
3 |
|
histones - metabolism |
3 |
|
hose |
3 |
|
hpv |
3 |
|
human papillomavirus |
3 |
|
humidity - adverse effects |
3 |
|
hydrogen-ion concentration |
3 |
|
id1 |
3 |
|
igf2 |
3 |
|
inhibitor of apoptosis proteins |
3 |
|
inhibitor of differentiation protein 1 - chemistry - deficiency - metabolism |
3 |
|
integration |
3 |
|
integrin |
3 |
|
integrin alpha6 |
3 |
|
integrin beta4 |
3 |
|
integrins - genetics - metabolism |
3 |
|
intracellular signaling peptides and proteins |
3 |
|
invasiveness |
3 |
|
laminectomy |
3 |
|
lung neoplasms - genetics - metabolism |
3 |
|
lymph nodes - metabolism |
3 |
|
lymphatic metastasis |
3 |
|
map kinase kinase 1 - metabolism |
3 |
|
mechanism |
3 |
|
mek |
3 |
|
membrane glycoproteins - metabolism |
3 |
|
metaphase - genetics |
3 |
|
mitogen-activated protein kinase 3 - metabolism |
3 |
|
mkk6 |
3 |
|
models, biological |
3 |
|
motoneurons |
3 |
|
motor neurons - cytology - pathology - physiology |
3 |
|
n-cadherin |
3 |
|
nasopharyngeal |
3 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
3 |
|
nasopharyngeal neoplasms - metabolism - mortality - pathology |
3 |
|
nasopharynx - metabolism |
3 |
|
neoplasm staging |
3 |
|
neoplasms, germ cell and embryonal |
3 |
|
nerve tissue proteins |
3 |
|
neuronal death |
3 |
|
neurotrophic factors |
3 |
|
new method |
3 |
|
newborn rat |
3 |
|
nitriles - pharmacology |
3 |
|
non-fibrillar collagens |
3 |
|
nonsmall cell lung carcinoma |
3 |
|
nuclear proteins |
3 |
|
oncogene proteins, viral - genetics |
3 |
|
opening reading frame |
3 |
|
orf |
3 |
|
ovarian |
3 |
|
ovarian diseases - etiology - metabolism - pathology |
3 |
|
ovary - cytology - enzymology |
3 |
|
ovulation |
3 |
|
oxidative stress |
3 |
|
oxidative stress - physiology |
3 |
|
papillomaviridae - classification - genetics - isolation & purification |
3 |
|
papillomaviridae - metabolism |
3 |
|
papillomavirus infections - complications |
3 |
|
paracrine |
3 |
|
pcr |
3 |
|
physical status |
3 |
|
polyploidy |
3 |
|
protein kinases - genetics |
3 |
|
protein-serine-threonine kinases |
3 |
|
protein-serine-threonine kinases - genetics - metabolism |
3 |
|
proteins - genetics - metabolism |
3 |
|
proteins - metabolism |
3 |
|
proto-oncogene proteins - genetics - metabolism |
3 |
|
proto-oncogene proteins c-bcl-2 - genetics - metabolism |
3 |
|
rad51 recombinase - metabolism |
3 |
|
rat (sprague dawley) |
3 |
|
rats, sprague-dawley |
3 |
|
receptor, epidermal growth factor - genetics - metabolism |
3 |
|
repressor proteins - genetics |
3 |
|
repressor proteins - genetics - metabolism |
3 |
|
repressor proteins - pharmacology |
3 |
|
reproducibility of results |
3 |
|
rho gtp-binding proteins - metabolism |
3 |
|
semen - enzymology |
3 |
|
sperm dna damage |
3 |
|
spermatozoa - physiology |
3 |
|
spinal cord - pathology - physiopathology |
3 |
|
spinal cord injuries - pathology - physiopathology |
3 |
|
spinal nerve roots - injuries |
3 |
|
staging |
3 |
|
superoxide dismutase |
3 |
|
superoxide dismutase - metabolism |
3 |
|
survival rate |
3 |
|
syrian hamster |
3 |
|
telomerase - genetics - metabolism |
3 |
|
temperature |
3 |
|
testicular neoplasms - drug therapy |
3 |
|
tgct |
3 |
|
therapeutic irrigation |
3 |
|
tissue array analysis |
3 |
|
tissue fixation - methods |
3 |
|
tissue microarray |
3 |
|
trans-activators |
3 |
|
uterus |
3 |
|
viral copy number |
3 |
|
viral load |
3 |
|
viral matrix proteins - genetics - metabolism - physiology |
3 |
|
virus integration - genetics |
3 |
|
xenopus proteins - genetics |
3 |
|
xeroderma pigmentosum group d protein - metabolism |
3 |
|
2-cell embryo |
2 |
|
allelic loss |
2 |
|
atm |
2 |
|
biological factors - physiology |
2 |
|
brain - growth and development |
2 |
|
cancer stem cells |
2 |
|
carcinoma, squamous cell - epidemiology - genetics - virology |
2 |
|
cd133 |
2 |
|
china - epidemiology |
2 |
|
cyclin d1 |
2 |
|
dna damage response |
2 |
|
eels. |
2 |
|
endocrinology. |
2 |
|
enkephalin |
2 |
|
epididymis |
2 |
|
esophageal neoplasms - epidemiology - genetics - virology |
2 |
|
esophagus |
2 |
|
f-box protein 4 |
2 |
|
genitalia, male - secretion |
2 |
|
geography |
2 |
|
hamster |
2 |
|
igf1r |
2 |
|
immortalized esophageal epithelial cells |
2 |
|
loh |
2 |
|
loss of heterozygosity |
2 |
|
male accessory sex glands |
2 |
|
metabolism. |
2 |
|
motoneuron disease |
2 |
|
motor neurons - physiology |
2 |
|
nadp - pharmacology |
2 |
|
neuromuscular diseases - physiopathology |
2 |
|
neuropeptides - analysis |
2 |
|
papillomaviridae - pathogenicity |
2 |
|
prognostic biomarker |
2 |
|
progression |
2 |
|
rad51 |
2 |
|
radioassay |
2 |
|
review |
2 |
|
risk factors |
2 |
|
somatostatin |
2 |
|
sperm-ovum interactions - physiology |
2 |
|
spermatozoa - drug effects - physiology |
2 |
|
spinal cord - analysis - growth and development |
2 |
|
stem cell |
2 |
|
substance p |
2 |
|
thyrotropin releasing hormone |
2 |
|
wobbler mice |
2 |
|
zygote |
2 |
|
5,6-dihydroxytryptamine - pharmacology |
1 |
|
accessory sex glands |
1 |
|
adrenal hyperplasia, congenital - pathology |
1 |
|
adrenogenital syndrome |
1 |
|
ageing |
1 |
|
aging - physiology |
1 |
|
amines - blood |
1 |
|
analysis of variance |
1 |
|
antibodies - diagnostic use |
1 |
|
antibodies, monoclonal - diagnostic use |
1 |
|
antigen-antibody complex |
1 |
|
autometallography |
1 |
|
autonomic innervation |
1 |
|
biotin - analogs & derivatives - metabolism |
1 |
|
blood glucose - analysis |
1 |
|
blood glucose - metabolism |
1 |
|
blood vessels - innervation |
1 |
|
calcitonin gene-related peptide (cgrp) |
1 |
|
carcinoma, squamous cell - metabolism - mortality - therapy - virology |
1 |
|
catalyzed reporter deposition |
1 |
|
cervical carcinoma |
1 |
|
chicken |
1 |
|
chickens |
1 |
|
chickens - blood |
1 |
|
chickens - metabolism |
1 |
|
chickens - physiology |
1 |
|
clitoris |
1 |
|
clitoris - innervation |
1 |
|
corticosterone - blood |
1 |
|
corticosterone - secretion |
1 |
|
cyproheptadine - pharmacology |
1 |
|
dexamethasone - pharmacology |
1 |
|
disease-free survival |
1 |
|
dna, complementary - metabolism |
1 |
|
dna, viral - genetics |
1 |
|
dysregulation |
1 |
|
endocrine cells |
1 |
|
esophageal neoplasms - blood supply - metabolism - pathology |
1 |
|
extracellular matrix |
1 |
|
fatty acids, nonesterified - blood |
1 |
|
fenclonine - pharmacology |
1 |
|
fluorescent antibody technique, indirect |
1 |
|
follow-up studies |
1 |
|
galanin |
1 |
|
genitalia, male - innervation |
1 |
|
glycosaminoglycan |
1 |
|
gold compounds |
1 |
|
growth hormone |
1 |
|
growth hormone - pharmacology |
1 |
|
growth hormone-releasing factor |
1 |
|
helospectin |
1 |
|
hpv testing |
1 |
|
immune sera |
1 |
|
immunization, passive |
1 |
|
in situ hybridization |
1 |
|
in situ hybridization - methods |
1 |
|
indicators and reagents - metabolism |
1 |
|
kinetics |
1 |
|
luteinizing hormone - blood |
1 |
|
luteinizing hormone - blood - secretion |
1 |
|
methysergide - pharmacology |
1 |
|
micrornas |
1 |
|
nanogold |
1 |
|
neovascularization, pathologic |
1 |
|
nerve net |
1 |
|
nervous system - metabolism |
1 |
|
neuropeptide |
1 |
|
neuropeptide tyrosine (neuropeptide y) |
1 |
|
neuropeptides - isolation & purification |
1 |
|
papillomaviridae - genetics |
1 |
|
papillomavirus infections - virology |
1 |
|
pargyline - pharmacology |
1 |
|
pentobarbital - pharmacology |
1 |
|
peptides - metabolism |
1 |
|
peptides - pharmacology |
1 |
|
peroxidase |
1 |
|
peroxidase - metabolism |
1 |
|
pituitary |
1 |
|
pituitary hormones - metabolism |
1 |
|
pituitary neoplasms - metabolism - pathology |
1 |
|
proteoglycan |
1 |
|
quipazine - pharmacology |
1 |
|
radioimmunoassay |
1 |
|
rat |
1 |
|
recombinant proteins - pharmacology |
1 |
|
sensitivity and specificity |
1 |
|
serotonin - pharmacology |
1 |
|
serotonin - physiology |
1 |
|
silver - metabolism |
1 |
|
silver enhancement |
1 |
|
somatostatin - blood - immunology |
1 |
|
somatostatin - immunology - physiology |
1 |
|
streptavidin - metabolism |
1 |
|
therapeutic potential |
1 |
|
tryptophan - pharmacology |
1 |
|
tumor virus infections - virology |
1 |
|
tyramide signal amplification |
1 |
|
tyramine - analogs & derivatives - metabolism |
1 |
|
uterine cervical neoplasms - genetics - pathology - virology |
1 |
|
uterine cervical neoplasms - metabolism - mortality - therapy - virology |
1 |
|
uterine cervix |
1 |
|
vasoactive intestinal polypeptide (vip) |
1 |
|
vasoconstrictor agents - isolation & purification |
1 |
|
vasodilator agents - isolation & purification |
1 |
|
zinc ions |
1 |
